Skip to main content

Table 2 Association between clinical characteristics and suboptimal 25-hydroxyvitamin D3 levels at time of diagnosis in melanoma patients

From: Serum 25-hydroxyvitamin D3 levels and vitamin D receptor variants in melanoma patients from the Mediterranean area of Barcelona

 

Variables*

 

VitD level sufficient >25 ng/mL n = 26(32%)

VitD level insufficient ≤25 ng/mL n = 55(68%)

OR (95%IC)

P

Clinical characteristic

Age at diagnosis of melanoma**

 

54 (36–65)

55 (37–68)

0.99 (0.96- 1.01)

0.553

 

Gender

Female

15 (57.7%)

23 (41.8%)

1

 
  

Male

11 (42.3%)

32 (58.2%)

1.9 (0.74- 4.88)

0.184

 

BMI basal (kg/m2)

Normal weight

9 (47.4%)

15 (34.1%)

1

 
  

Overweight

6 (31.6%)

18 (40.9%)

0.56 (0.16- 1.92)

0.353

  

Obese

4 (21.1%)

11 (25%)

0.61 (0.16- 2.49)

0.487

 

Season blood sampling

Spring- Summer

18 (69.2%)

20 (38.5%)

1

 
  

Autumn- Winter

8 (30.8%)

32 (61.5%)

3.6 (1.32- 9.81)

0.012

 

Fitzpatrick skin type

Dark

16 (61.5%)

21 (38.2%)

1

 
  

Fair

10 (38.5%)

34 (61.8%)

2.59 (0.99- 6.76)

0.052

 

Hair color

Dark

8 (30.8%)

32 (61.5%)

1

 
  

Light

8 (32%)

15 (29.4%)

0.89 (0.32- 2.49)

0.818

 

Eye color

Dark

11 (44%)

27 (54%)

1

 
  

Light

14 (56%)

23 (46%)

0.67 (0.26- 1.76)

0.415

 

Actinic damage

No

21 (80.8%)

41 (78.8%)

1

 
  

Yes

5 (19.2%)

11 (21.2%)

0.89 (0.27- 2.89)

0.843

 

Nevus Number

<50

12 (54.5%)

22 (53.7%)

1

 
  

≥50

10 (45.5%)

19 (46.3%)

0.97 (0.34- 2.73)

0.946

Habits of solar exposure and photoprotection

Solar exposure before 10 years old

Severe/Moderate

21 (80.8%)

38 (73.1%)

1

 
  

None/Mild

5 (19.2%)

14 (26.9%)

1.55 (0.49- 4.9)

0.458

 

Solar exposure 10–18 years old

Severe/Moderate

23 (88.5%)

34 (66.7%)

1

 
  

None/Mild

3 (11.5%)

17(33.3%)

3.83 (1.01- 14.5)

0.049

 

Solar exposure > 18 years old

Severe/Moderate

11 (91.7%)

18 (64.3%)

1

 
  

None/Mild

1 (8.3%)

10 (35.7%)

6.11 (0.68- 54.5)

0.105

 

Photoprotection before 10 years old

Never

17 (68%)

30 (63.8%)

1

 
  

Usually

8 (32%)

17 (36.2%)

1.20 (0.43- 3.37).33)

0.724

 

Photoprotection 10–18 years old

Never

14 (73.3%)

19 (63.3%)

1

 
  

Usually

5 (26,3%)

11 (36.7%)

1.62 (0.46- 5.73)

0.453

 

Photoprotection over 18 years old

Never

15 (60%)

21 (45.7%)

1

 
  

Usually

10 (40%)

25 (54.3%)

1.79 (0.66- 4.80)

0.250

Melanoma characteristic

Number of Melanoma

SPM

24 (92.3%)

49 (89.1%)

1

 
  

MPM

2 (7.7%)

6 (10.9%)

0.68 (0.13- 3.63)

0.652

 

Breslow thickness+

<= 0.75

22 (46.8%)

9 (42.9%)

1

 
  

0.75-1

11 (23.4%)

4 (19.0%)

0.89 (0.22- 3.54)

0.867

  

> = 1

14 (29.8%)

8 (38.1)

1.4 (0.43- 4.48)

0.574

 

Breslow thickness+**

 

0.8 (0.52- 1.3)

0.8 (0.52- 1.2)

1.1 (0.78- 1.54)

0.583

  1. VitD = 25-hydroxyvitamin D3 *Not all the patients have complete data +Breslow thickness was analized as categorical and continuos variable **The medians (25th - 75th percentiles) of 25-hydroxyvitamin D3 levels were reported for age at diagnosis of melanoma and breslow thickness.